NYSE:HQL Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News $13.22 +0.01 (+0.08%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$13.15▼$13.2950-Day Range$13.21▼$14.1752-Week Range$13.03▼$16.33Volume62,581 shsAverage Volume63,478 shsMarket Capitalization$332.35 millionP/E RatioN/ADividend Yield12.25%Price TargetN/A ProfileProfileChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Tekla Life Sciences Investors (NYSE:HQL) StockTekla Life Sciences Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.Read More Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address HQL Stock News HeadlinesMay 18, 2023 | americanbankingnews.comTekla Life Sciences Investors (HQL) To Go Ex-Dividend on May 24thMay 17, 2023 | msn.comTekla Life Sciences Investors (HQL) Declares $0.32 DividendMay 27, 2023 | Behind the Markets (Ad)⚡ 2,467% Return on Israeli Laser Company?This advanced laser system is active in 80 countries around the world. And at the center of this massive market is a small firm in Israel. Our research shows that anyone who gets in today could see a return of 2,467%. But that's only if the company doesn't get taken over for a fast 300% gain first.May 15, 2023 | msn.comTekla Life Sciences dividend declines by 3% to $0.32March 21, 2023 | seekingalpha.comHQL Tekla Life Sciences InvestorsNovember 18, 2022 | msn.comTekla Life Sciences: Dividend InsightsNovember 2, 2022 | fool.comTekla Life Sciences Investors (NYSE: HQL)July 14, 2022 | seekingalpha.comHQL: A Biotechnology Equity CEF With No LeverageMay 27, 2023 | Behind the Markets (Ad)⚡ 2,467% Return on Israeli Laser Company?This advanced laser system is active in 80 countries around the world. And at the center of this massive market is a small firm in Israel. Our research shows that anyone who gets in today could see a return of 2,467%. But that's only if the company doesn't get taken over for a fast 300% gain first.June 8, 2022 | news.yahoo.comTekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear CapsuleMay 17, 2022 | seekingalpha.comTekla Life Sciences cuts dividend by 10% to $0.35April 27, 2022 | seekingalpha.comHQL: Buy For The Yield, If You Can Stomach The DepreciationFebruary 11, 2022 | seekingalpha.comTekla Life Sciences Investors: Buy For Steady, Quarterly DividendJanuary 18, 2022 | nasdaq.comTekla Life Sciences Investors Shares Approach 52-Week Low - Market MoverAugust 15, 2021 | forbes.com5 Dividend Funds Yielding Up To 27.2%August 13, 2021 | nasdaq.comTekla Life Sciences Investors Shares Close in on 52-Week High - Market MoverFebruary 17, 2021 | benzinga.comTekla Life Sciences Increases Dividend From $0.40 To $0.43January 9, 2021 | seekingalpha.comTekla Life Sciences Investors: 8% Yield, 7% DiscountDecember 21, 2020 | finance.yahoo.comTekla Life Sciences Investors Declares Cash DistributionNovember 24, 2020 | benzinga.comUnderstanding Tekla Life Sciences's Ex-Dividend DateNovember 16, 2020 | finance.yahoo.comTekla Life Sciences Investors Declares DistributionNovember 9, 2020 | seekingalpha.comHQH: Deep Discount Leads To High YieldMay 15, 2020 | www.nasdaq.comHQL TeklaLife Sciences Investors Common StockMarch 19, 2020 | finance.yahoo.comTekla Life Sciences Investors Announce Renewal of Share Repurchase ProgramFebruary 18, 2020 | seekingalpha.comTekla Life Sciences declares $0.39 dividendFebruary 18, 2020 | finance.yahoo.comTekla Life Sciences Investors Declares Stock DistributionJanuary 24, 2020 | finance.yahoo.comTop Picks 2020- Tekla Life Sciences Fund HQLSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address HQL Company Calendar Ex-Dividend for 3/31 Dividend2/24/2023Dividend Payable3/31/2023Ex-Dividend for 6/30 Dividend5/24/2023Today5/27/2023Dividend Payable6/30/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Investment offices, not elsewhere classified Sub-IndustryN/A SectorFinance Current SymbolNYSE:HQL CUSIPN/A CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares25,140,000Free Float22,615,000Market Cap$332.35 million OptionableNot Optionable Beta0.83 Key ExecutivesDan OmsteadPresident & TrusteeJason C. AkusSenior Vice President-ResearchLaura F. WoodwardSecretary, Treasurer & Chief Compliance OfficerTimothy L. GasperoniSenior Vice President-ResearchKey CompetitorsPutnam Premier Income TrustNYSE:PPTDWS Municipal Income TrustNYSE:KTFPutnam Municipal Opportunities TrustNYSE:PMOTortoise Energy InfrastructureNYSE:TYGBlackRock MuniHoldings New Jersey Quality FundNYSE:MUJView All CompetitorsInstitutional OwnershipAmeriprise Financial Inc.Bought 15,196 shares on 5/22/2023Ownership: 0.540%Cetera Investment AdvisersBought 13,123 shares on 5/15/2023Ownership: 0.369%Stephens Inc. ARSold 2,518 shares on 5/15/2023Ownership: 0.045%UBS Group AGSold 6,211 shares on 5/12/2023Ownership: 0.183%NewEdge Advisors LLCBought 861 shares on 5/12/2023Ownership: 0.116%View All Institutional Transactions HQL Stock - Frequently Asked Questions How have HQL shares performed in 2023? Tekla Life Sciences Investors' stock was trading at $14.21 on January 1st, 2023. Since then, HQL shares have decreased by 7.0% and is now trading at $13.22. View the best growth stocks for 2023 here. Are investors shorting Tekla Life Sciences Investors? Tekla Life Sciences Investors saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 39,800 shares, a drop of 27.2% from the April 30th total of 54,700 shares. Based on an average trading volume of 75,500 shares, the short-interest ratio is presently 0.5 days. View Tekla Life Sciences Investors' Short Interest. How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors? Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, May 16th. Investors of record on Thursday, May 25th will be given a dividend of $0.32 per share on Friday, June 30th. This represents a $1.28 dividend on an annualized basis and a yield of 9.68%. The ex-dividend date of this dividend is Wednesday, May 24th. Read our dividend analysis for HQL. What ETFs hold Tekla Life Sciences Investors' stock? ETFs with the largest weight of Tekla Life Sciences Investors (NYSE:HQL) stock in their portfolio include First Trust Income Opportunities ETF (FCEF), Is Tekla Life Sciences Investors a good dividend stock? Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.62 per share and currently has a dividend yield of 12.26%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL. What other stocks do shareholders of Tekla Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY). What is Tekla Life Sciences Investors' stock symbol? Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL." Who are Tekla Life Sciences Investors' major shareholders? Tekla Life Sciences Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (1.23%), Wolverine Asset Management LLC (1.22%), Allspring Global Investments Holdings LLC (0.87%), LPL Financial LLC (0.67%), Ameriprise Financial Inc. (0.54%) and 180 Wealth Advisors LLC (0.44%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz. View institutional ownership trends. How do I buy shares of Tekla Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Tekla Life Sciences Investors' stock price today? One share of HQL stock can currently be purchased for approximately $13.22. How much money does Tekla Life Sciences Investors make? Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $332.35 million. How can I contact Tekla Life Sciences Investors? Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577. This page (NYSE:HQL) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tekla Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.